SeaFort helps fund rollout of nat’l platform for orthotics 

HALIFAX, Nova Scotia – SeaFort Capital has made a majority investment in The Médicus Group which represents Mable Health’s first investment in the orthotics, prosthetics and mobility aids industry. Mable Health acquired Médicus from Metro and the Bleau family. “We are very excited to be partnered with SeaFort Capital and to support the growth of the Mable Health business,” said Michel Lanctôt, a general manager at Medicus who will now serve as president of Mable Health and Medicus and who will oversee Mable Health’s rollout of a national platform. “We have a successful track record of operating an industry leading business, which we are excited to leverage in expanding Mable Health across Canada.” Headquartered in Montreal and founded in 1957, Médicus operates 19 clinics and employes more than 250 staff, including 145 orthotists, prosthetics, technicians and other professionals. In addition to SeaFort Capital Fund II LP, Michel Coutu, Jacinte Bleau, and Michel Lanctôt are now shareholders in Mable Health, with Médicus existing as a wholly owned subsidiary. Coutu will serve as board chair for Mable Health. He previously served as the president and CEO of The Jean Coutu Group USA, was a member of the board of directors of the National Association of Chain Drug Stores in the United States and was co-chair of the board of directors of Rite Aid. Based in Halifax, Nova Scotia, SeaFort Capital is a private equity firm that invests in lower-mid-market Canadian businesses with EBITDA ranging from $2 million to $15 million.